Current options for vaccine delivery systems by mucosal routes

Journal of Controlled Release

Volumn 48, Issue 2-3, 1997, Pages 243-257

  Mestecky, J ^a   Moldoveanu, Z ^a   Michalek, S M ^a   Morrow, C D ^a   Compans, R W ^b   Schafer, D P ^c   Russell, M W ^a  

^a University of Alabama at Birmingham   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Zynaxis Inc   (United States)

Author keywords

Liposomes; Microspheres; Mucosal immunity; Vaccine delivery systems; Vaccines; Vectors

Indexed keywords

DRUG CARRIER; IMMUNOGLOBULIN A; LIPOSOME; LIVE VACCINE; MICROSPHERE; SECRETORY IMMUNOGLOBULIN; VACCINE; VIRUS VECTOR;

ANTIBODY RESPONSE; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG TOLERABILITY; IMMUNE RESPONSE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION;

EID: 0030817199     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)00036-9     Document Type: Article

References (110)

1. J.R. McGhee and J. Mestecky, In defense of mucosal surfaces. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens, Infect. Dis. Clin. North Am. 4 (1990) 315-341.
2. C.D. Alley and J. Mestecky, The mucosal immune system, In: G. Bird and J.E. Calvert (Eds.), B Lymphocytes in Human Disease, Oxford, Oxford University Press, 1988, pp. 222-254.
3. M.E. Conley and D.L. Delacroix, Intravascular and mucosal immunoglobulin A: two separate but related systems of immune defense?, Ann. Intern. Med. 106 (1987) 892-899.
4. J.R. McGhee, J. Mestecky, M.T. Dertzbaugh, J.H. Eldridge, M. Hirasawa and H. Kiyono, The mucosal immune system: From fundamental concepts to vaccine development, Vaccine 10 (1992) 75-88.
5. J. Mestecky, The common mucosal immune system and current strategies for induction of immune responses in external secretions, J. Clin. Immunol. 7 (1987) 265-276.
6. J. Mestecky and J.R. McGhee (Eds.), New strategies for oral immunization, Curr. Top. Microbiol. Immunol. 146 (1989) 3-237.
7. D.T. O'Hagan, Oral delivery of vaccines: formulation and clinical pharmacokinetic considerations, Clin. Pharmacokinet. 22 (1992) 1-10.
8. C.A. Gilligan and L.W. Po, Oral enteric vaccines - clinical trials, J. Clin. Pharm. Ther. 16 (1991) 309-335.
9. A.J. Husband, Novel vaccination strategies for the control of mucosal infection, Vaccine 11 (1993) 107-112.
10. W.N. Burnette, Vaccine development: necessity as the mother of invention, New Biol. 4 (1992) 269-273.
11. M. Quiding, A. Nordstrom, A. Kilander, G. Andersson, L.A. Hanson, J. Holmgren and C. Czerkinsky, Intestinal immune responses in humans, J. Clin. Invest. 88 (1991) 143-148.
12. P. Brandtzaeg, Overview of the mucosal immune system, Curr. Top. Microbiol. Immunol. 146 (1989) 13-25.
13. J. Mestecky, C. Lue, and M.W. Russell, Selective transport of IgA. Cellular and molecular aspects, Gastroenterol. Clin. North Am. 20 (1991) 441-471.
14. J. Mestecky and J.R. McGhee, Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response, Adv. Immunol. 40 (1987) 153-245.
15. I.M. Onorato, J.F. Modlin, A.M. McBean, M.L. Thomas, G.A. Losonsky and R.H. Bernier, Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccine, J. Infect. Dis. 163 (1991) 1-6.
16. J. R. McGhee and J. Mestecky, The mucosal immune system in HIV infection and prospects for mucosa immunity to AIDS, AIDS Res. Rev. 2 (1992) 289-312.
17. C.J. Miller, Use of SIV/rhesus macaque model of the heterosexual transmission of HIV in AIDS vaccine research, Vaccine Res. 1 (1992) 295-301.
18. L. Lefrancois, TCR γδST cells: do they have potential for anti-HIV activity?, Vaccine Res. 1 (1992) 203-206.
19. T. Lehner, C. Panagiotidi, L.A. Bergmeier, L. Tao, R. Brookes and S. Adams, A comparison of the immune response following oral, vaginal, or rectal route of immunization with SIV antigens in nonhuman primates, Vaccine Res. 1 (1992) 319-330.
20. J.J. Cebra, E.R. Cebra, E.R. Clough, J.A. Fuhrman, J.L. Komisar, P.A. Schweitzer and R.D. Shahin, IgA commitment: models for B-cells differentiation and possible roles for T-cells in regulating B-cell development, Ann. N.Y. Acad. Sci. 409 (1983) 25-38.
21. J.M. Phillips-Quagliata and M.E. Lamm, Migration of lymphocytes in the mucosal immune system, In: A.J. Husband (Ed.), Migration and Homing of Lymphoid Cells, Vol.II., CRC Press, Boca Raton, FL, 1988, pp. 53-75.
22. R. Scicchitano, A. Stanisz, P.B. Ernst and J. Bienenstock, A common immune system revisited, In: A. J. Husband (Ed.), Migration and Homing of Lymphoid Cells, Vol. II., CRC Press, Boca Raton, FL, 1988, pp. 1-34.
23. J.R. McGhee, J. Mestecky, C.O. Elson and H. Kiyono, Regulation of IgA synthesis and immune response by T cells and interleukins, J. Clin. Immunol. 9 (1989) 175-199.
24. P.C. Montgomery, J. Cohn and E.T. Lally, The induction and characterization of secretory antibodies, Adv. Exp. Med. Biol. 45 (1974) 453-462.
25. C. Czerkinsky, S.J. Prince, S.M. Michalek, S. Jackson, M.W. Russell, Z. Moldoveanu, J.R. McGhee and J. Mestecky, IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans, Proc. Natl. Acad. Sci. USA 84 (1987) 2449-2453.
26. C. Czerkinsky, A.-M. Svennerholm, M. Quiding, R. Jonsson and J. Holmgren, Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans, Infect. Immun. 59 (1991) 996-1001.
27. A. Kantele, J.M. Kantele, H. Arvilommi and P.H. Mäkelä, Active immunity is seen as a reduction in the cell response to oral live vaccine, Vaccine 9 (1991) 428-431.
28. A. Kantele, Antibody secreting cells in the evaluation of the immunogenicity of an oral vaccine, Vaccine 8 (1990) 321-326.
29. P. Brandtzaeg and T.S. Halstensen, Immunology and immunopathology of tonsils, Adv. Otorhinolaryngol. 47 (1992) 64-75.
30. D. Nadal and P.L. Ogra, Tonsils: the gatekeeper of mucosal immunity, Adv. Otorhinolaryngol. 47 (1992) 76-79.
31. P.L. Ogra, Effect of tonsillectomy and adenoidectomy on nasopharyngeal antibody response to poliovirus, N. Engl. J. Med. 284 (1971) 59-64.
32. J.M. Langman and R. Rowland, The number and distribution of lymphoid follicles in the human large intestine, J. Anat. 194 (1986) 189-194.
33. A.D. O'Leary and E.C. Sweeney, Lymphoglandular complexes of the colon: structure and distribution, Histopathology 10 (1986) 267-283.
34. S.S. Crago, W.H. Kutteh, I. Moro, M.R. Allansmith, J. Radl, J. Haaijman and J. Mestecky, Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues, J. Immunol. 132 (1984) 16-18.
35. J. Mestecky and M.W. Russell, IgA subclasses, Monogr. Allergy 19 (1986) 277-301.
36. W.H. Kutteh and J. Mestecky, Concept of Mucosal Immunology, In: R.A. Bronson, N.J. Alexander, D.J. Anderson, D.W. Branch and W.H. Kutteh (Eds.), Reproductive Immunology, Ch. 2, Blackwell Science, Cambridge, MA, 1996, pp. 28-51.
37. B.D. Forrest, The need for consideration of mucosal immunity in vaccine approaches to AIDS, Vaccine Res. 1 (1992) 137-142.
38. M.W. Russell, Z. Moldoveanu, P.L. White, G.J. Sibert, J. Mestecky and S.M. Michalek, Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and cholera toxin B subunit, Infect. Immun. 64 (1996) 1273-1283.
39. J. Mestecky and J.H. Eldridge, Targeting and controlled release of antigens for the effective induction of secretory antibody responses, Curr. Opin. Immunol. 3 (1991) 492-495.
40. D. Medaglini, G. Pozzi, T.P. King and V.A. Fischetti, Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization, Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 6868-6872.
41. J. Mestecky and J.R. McGhee, Prospects for human mucosal vaccines, Adv. Exp. Med. Biol. 327 (1992) 13-23.
42. S.M. Michalek, J.H. Eldridge, R. Curtiss III and K.L. Rosenthal, Antigen delivery systems: new approach to mucosal immunization, In: P.L. Ogra, J. Mestecky, M.E. Lamm, W Strober, J.R. McGhee and J. Bienenstock (Eds.), Handbook of Mucosal Immunology, Academic Press, San Diego, CA, 1994, pp. 373-386.
43. S.M. Michalek, N.K. Childers and M.T. Dertzbaugh, Vaccination strategies for mucosal pathogens, In: J.A. Roth, C.A. Bolin, K.A. Brogden, F.C. Minion, and M.J. Wannemuehler (Eds.), Virulence Mechanisms of Bacterial Pathogens, 2nd edn. ASM Publications, Washington, DC, 1995, pp. 269-302.
44. J. Srinivasan, S. Tinge, R. Wright, J.C. Herr and R. Curtiss III, Oral immunization with attenuated Salmonella expressing human sperm antigen induces antibodies in serum and the reproductive tract. Biol. Reprod. 53 (1995) 462-471.
45. 2-microglobulin-deficient mice can be protected against influenza A virus infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase, J. Immunol. 15 (1993) 5484-5493.
46. C.A. Meitin, B.S. Bender and PA. Small Jr., Enteric immunization of mice against influenza with recombinant vaccinia, Proc. Natl. Acad. Sci. USA 91 (1994) 11187-11191.
47. A.B. Kulkarni, P.L. Collins, I. Bacik, J.W. Yewdell, J.R. Bennink, J.E. Crowe Jr. and B.R. Murphy, Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus, J. Virol. 69 (1995) 1261-1264.
48. Z. Moldoveanu, M.W. Russell, H.-Y. Wu, W-Q. Huang and J. Mestecky, Compartmentalization within the mucosal immune system, In: J. Mestecky, M.W. Russell, S. Jackson, S.M. Michalek, H. Tlaskalová-Hogenová and J. Sterzl (Eds.), Adv. Exp. Med. Biol., 371A Plenum Press, New York, 1995, pp. 97-102.
49. J. M. Hogle, M. Chow and D.J. Filman, Three-dimensional structure of poliovirus at 2.9 Å resolution, Science 229 (1985) 1358-1365.
50. J.W. Almond and K.L. Burke, Poliovirus as a vector for the presentation of foreign antigens, Semin. Virol. 1 (1990) 11-20.
51. N.M. Mattion, P.A. Reilly, S.J. DiMichele, J.C. Crowley and C. Weeks-Levy, Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses, J. Virol. 68 (1994) 3925-3933.
52. R. Altmeyer, N. Escriou, M. Girard, A. Palmenberg and S. Van der Werf, Attenuated mengo virus as a vector for immunogenic human immunodeficiency virus type 1 glycoprotein 120, Proc. Natl. Acad. Sci. USA. 91 (1994) 9775-9779.
53. C.D. Morrow, D.C. Porter, D.C. Ansardi, Z. Moldoveanu and P.N. Fultz, New approaches for mucosal vaccines for AIDS: encapsidation and serial passage of poliovirus replicons that express HIV-1 proteins on infection, AIDS Res. Hum. Retroviruses 10 (1994) S61-66.
54. Z. Moldoveanu, D.C. Porter, A. Lu, S. McPherson and C.D. Morrow, Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins, Vaccine 13 (1995) 1013-1022.
55. T. Muester, B. Ferko, A. Klima, M. Purtscher, A. Trkola, P. Schultz, A. Grassauer, O.G. Engelhardt, A. Garcia-Sastre, P. Palese and H. Katinger, Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus, J. Virol. 69 (1995) 6678-6686.
56. S. Li, M. Rodrigues, D. Rodriguez, H.R. Rodriguez, M. Esteban, P. Palese, R.S. Nussenzweig and F. Zavala, Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated immunity against malaria, Proc. Natl. Acad. Sci. USA 90 (1993) 5214-5218.
57. W.S. Gallichan, D.C. Johnson, F.L. Graham and K.L. Rosenthal, Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B, J. Infect. Dis. 168 (1993) 622-629.
58. G.W. Both, L.J. Lockett, V Janardhana, S.J. Edwards, A.R. Bellamy, F.L. Graham, L. Prevec and M.E. Andrew, Protective immunity to rotavirus-induced diarrhea is passively transferred to newborn mice from naive dams vaccinated with a single dose of recombinant adenovirus expressing rotavirus VP7sc, Virology 193 (1993) 940-950.
59. K. Berencsi, R.F. Rando, C. Detaisne, E. Paoletti, S.A. Plotkin and E. Gonczol, Murine cytotoxic T cell response specific for human cytomegalovirus glycoprotein B (gB) induced by adenovirus and vaccinia virus recombinants expressing gB, J. Gen. Virol. 74 (1993) 2507-2512.
60. R.J. Natuk, M.D. Lubeck, P.K. Chanda, M. Chengalvala, M.S. Wade, S.C.S. Murthy, J. Wilhelm, S.K. Vernon, S.K. Dheer, S. Mizutani, S.-G. Lee, K.K. Murthy, J.W. Eichberg, A.R. Davis and P. P. Hung, Immunogenicity of recombinant human adenovirus-human immunodeficiency virus in chimpanzees, AIDS Res. Hum. Retrovir. 9 (1993) 395-404.
61. R. Ray, V.E. Brown and R.W. Compans, Glycoprotiens of human parainfluenza type 3 virus: characterization and evaluation as a subunit vaccine. J. Infect. Dis. 152 (1985) 1219-1230.
62. R. Ray, B.J. Glaze, Z. Moldoveanu and R.W. Compans, Intranasal immunization with envelope glycoproteins of human parainfluenza virus type 3, J. Infect. Dis. 157 (1988) 648-654.
63. R. Ray and R.W. Compans, Glycoproteins of human parainfluenza virus type 3: affinity purification, antigenic characterization, and reconstitution into lipid vesicles. J. Gen. Virol. 68 (1987) 409-418.
64. R. Ray, B.J. Glaze and R.W. Compans, The role of individual glycoproteins of human parainfluenza virus type 3 in the induction of a protective immune response. J. Virol. 62 (1988) 783-787.
65. N.K. Childers and S.M. Michalek, Liposomes, In: D.T. O'Hagan (Ed.), Novel Delivery Systems for Oral Vaccine Development, CRC Press, Boca Raton, FL, 1994, pp. 241-254.
66. G.F.A. Kersten and D.J.A. Crommelin, Liposomes and ISCOMs as vaccine formulation. Biochim. Biophys. Acta 1241 (1995) 117-138.
67. A. deHaan, K.B. Renegar, P.A. Small Jr. and J. Wilschut, Induction of a secretory IgA response in the murine female urogenital tract by immunization of the lungs with liposome-supplemental viral subunit antigen, Vaccine 13 (1995) 613-616.
68. E. Harokopakis, N.K. Childers, S.M. Michalek, S.S. Zhang and M. Tomasi, Conjugation of cholera toxin or its B subunit to liposomes for targeted delivery of antigens. J. Immunol. Methods 185 (1995) 31-42.
69. J.H. Eldridge, R.M. Gilley, J.K. Staas, Z. Moldoveanu, J.A. Meulbroek and T.R. Tice, Biodegradable microspheres: vaccine delivery system for oral immunization, Curr. Top. Microbiol. Immunol., 146 (1989) 59-66.
70. J. Mestecky, Z. Moldoveanu, M. Novak, W.-Q. Huang, R.M. Gilley, J.K. Staas, D.P. Schafer and R.W. Compans, Biodegradable microspheres for the delivery of oral vaccines, J. Control. Release 28 (1994) 131-141.
71. J.D. Duncan, R.M. Gilley, D.P. Schafer, Z. Moldoveanu and J. Mestecky, Poly(lactide-co-glycolide) microencapsulation of vaccines for mucosal immunization, In: H. Kiyono, P.L. Ogra, and J.R. McGhee (Eds.), Mucosal Vaccines, Academic Press, San Diego, CA, 1996, p. 159-173.
72. D.H. Lewis, Controlled release of bioactive agents from lactide/gycolide polymers, In: M. Chasin and R. Langer (Eds.), Biodegradable Polymers as Drug Delivery Systems, Marcel Dekker, Inc., New York, 1990, pp. 1-41.
73. D.T. O'Hagan, J.P. McGee, J. Holmgren, A. McI, Mowat, A.M. Donachie, K.H.G. Mills, W Gaisford, D. Rahman and S.J. Challacombe, Biodegradable microparticles for oral immunization, Vaccine 11 (1993) 149-154.
74. Z. Moldoveanu, M. Novak, W.-Q.-Huang, R.M. Gilley, J.K. Staas, D. Schafer, R.W. Compans and J. Mestecky, Oral immunization with influenza virus in biodegradable microspheres, J. Infect. Dis., 167 (1993) 84-90.
75. P.A. Marx, R.W. Compans, A. Gettie, J.K. Staas, R.M. Gilley, M.J. Mulligan, G.V. Yamshchikov, D. Chen and J.H. Eldridge, Protection against vaginal SIV transmission with microencapsulated vaccine, Science 260 (1993) 1323-1327.
76. C.O. Tacket, R.H. Reid, E.C. Boedeker, G. Losonsky, J.P. Nataro, H. Bhagat and R. Edelman, Enteral immunization and challenge of volunteers given enterotoxigenic Escherichia coli CFA/II encapsulated in biodegradable microspheres, Vaccine 12 (1994) 1270-1274.
77. S. Gould-Fogerite, Y. Edghill-Smith, M. Kheiri, Z. Wang, K. Das, C. Feketova, M. Canki and R.J. Mannino, Lipid matrix-based subunit vaccines: a structure-function approach to oral and parenteral immunization, AIDS Res. Human Retrovir. 10 (1994) S99-S103.
78. B.M. Ohlsson-Wilhelm, J.D. Duncan, J. Mestecky and R.W. Compans, Mucosal immunization against influenza virus using bioadhesive polymers, Proceedings: Options for the Control of Influenza III, 1996.
79. R.W. Compans, J.D. Duncan, P.X. Wang, C.M. Harrington, D.P Schafer, Y. Matsuoka, A.Z. Kapikian, L.J. Saif, R. Hesse, J. Mestecky and M. Novak, Improved liquid and solid oral delivery systems for attenuated live rotavirus vaccines, In: Proceedings of the Fifth Rotavirus Workshop: Current Issues and Future Developments, 1996.
80. G.F. Rimmelzwaan and A.D.M.E. Osterhaus, A novel generation of viral vaccines based on the ISCOM matrix, In: M.F. Powell and M.J. Newman (Eds.), Vaccine Design: The Subunit and Adjuvant Approach, Plenum Press, New York, 1995, pp. 543-558.
81. J. Holmgren, N. Lycke and C. Czerkinsky, Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems, Vaccine 11 (1993) 1179-1184.
82. C. Czerkinsky, M.W. Russell, N. Lycke, M. Lindblad and J. Holmgren, Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues, Infect. Immun. 57 (1989) 1072-1077.
83. C.O. Elson, Cholera toxin and its subunits as potential oral adjuvants, Curr. Topics Microbiol. Immunol. 146 (1989) 29-33.
84. S. Tamura, A. Yamanaka, M. Shimohara, T. Tomita, K. Komase, Y. Tsuda, Y. Suzuki, T. Nagamine, K. Kawahara, H. Danbara, C. Aizawa, A. Oya and T. Kurata, Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine, Vaccine 12 (1994) 419-426.
85. A. Tommaso, G. Saletti, M. Pizza, R. Rappuoli, G. Dougan, S. Abrignani, G. Douce and M.T. De Magistris, Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant, Infect. Immun. 64 (1996) 974-979.
86. B.L. Dickinson and J.D. Clements, Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity, Infect. Immun. 63 (1995) 1617-1623.
87. H.-Y. Wu and M.W. Russell, Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit, Infect. Immun. 61 (1993) 314-322.
88. M.T. Dertzbaugh, D.L. Peterson and F.L. Macrina, Cholera toxin B-subunit gene fusion: structural and functional analysis of the chimeric protein, Infect. Immun. 58 (1990) 70-79.
89. E.K. Jagusztyn-Krynicka, J.E. Clark-Curtiss and R. Curtiss, Escherichia coli heat-labile toxin subunit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: importance of the linker for antigenicity and biological activities of the hybrid proteins, Infect. Immun. 61 (1993) 1004-1015.
90. T.K. Sixma, S.E. Pronk, K.H. Kalk, E.S. Wartna, B.A.M. van Zanten, B. Witholt and W.G.J. Hol, Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli, Nature 351 (1991) 371-377.
91. G. Hajishengallis, S.K. Hollingshead, T. Koga and M.W. Russell, Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits, J. Immunol. 154 (1995) 4322-4332.
92. G. Hajishengallis, E. Harokopakis, S.K. Hollingshead, M.W. Russell and S.M. Michalek, Construction and oral immunogenicity of a Salmonella typhimurium strain expressing a streptococcal adhesin linked to the A2/B subunits of cholera toxin, Vaccine 14 (1996) 1545-1548.
93. H.L Davis, B.A. Demeneix, B. Quantin, J. Coulombe and R.G. Whalen, Plasmid DNA is superior to viral vectors for direct gene transfer in adult mouse skeletal muscle, Hum. Gene Ther. 4 (1993) 733-740.
94. E.F. Fynan, R.G. Webster, D.H. Fuller, J.R. Haynes, J.C. Santoro and H.L. Robinson, DNA vaccines: protective immunizations by parental, mucosal and gene-gun inoculations, Proc. Natl. Acad. Sci. USA 90 (1993) 11478-11482.
95. G. Ascadi, G. Dickson, D.R. Love, A. Jani, F.S. Walsh, A. Gurusinghe, J.A. Wolff and K.E. Davis, Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs, Nature 352 (1991) 815-818.
96. J.A. Wolff, R.W Malone, P. Williams, W. Chong, G. Ascadi, A. Jani and P.L. Felgner, Direct gene transfer into mouse muscle in vivo, Science 247 (1990) 1465-1468.
97. T. Osno, Y. Fujino, T. Tsuchiya and M. Tsuda, Plasmid DNAs directly injected into mouse brain with lipofectin can be incorporated and expressed by brain cells, Neurosci. Lett. 117 (1990) 259-263.
98. S. Jiao, G. Ascadi, A. Jani, P.L. Felgner and J.A. Wolff, Persistence of plasmid DNA and expression in rat brain cells in vivo, Exp. Neurol. 115 (1992) 400-413.
99. B.L. Davidson and B.J. Roessler, Direct plasmid mediated transfection of adult murine brain cells in vivo using cationic liposomes, Neurosci. Lett. 167 (1994) 5-10.
100. E. Hansen, K. Fernandes, G. Goldspink, P. Butterworth, P.K. Umeda and K.-C. Chang, Strong expression of foreign genes following direct injection into fish muscle, FEBS Lett. 290 (1991) 73-76.
101. R.N. Kitsis, P.M. Buttrick, E.M. McNally, M.L. Kaplan and L.A. Leinwand, Hormonal modulation of a gene injected into rat heart in vivo, Proc. Natl. Acad. Sci. USA 88 (1991) 4138-4142.
102. H. Lin, M.S. Parmacek, G. Morle, S. Bolling, and J.M. Leiden, Expression of recombinant genes in myocardium in vivo after direct injection of DNA, Circulation 82 (1990) 2217-2221.
103. J.A. Wolff, G. Acsadi, P. Williams and A. Jani, Long-term persistence of plasmid DNA and foreign gene expression in mouse model, Hum. Mol. Genet. 1 (1992) 363.
104. D.-C. Tang, M. DeVit and S.A. Johnson, Genetic immunization is a simple method for eliciting an immune response, Nature 356 (1992) 152-154.
105. J.B. Ulmer, J.J. Donnelly, S.E. Parker, G.H. Rhodes, P.L. Felgner, V.J. Dwarki, S.H. Gromkowski, R.R. Deck, C.M. DeWitt, A. Friedman, L.A. Hawe, K.R. Leander, D. Martinez, H.C. Perry, J.W. Shiver, D.L. Montgomery and M.A. Liu, Heterologous protection against influenza by injection of DNA encoding a viral protein, Science 259 (1993) 1745-1749.
106. B. Wang, K.E. Ugen, V. Srikantan, M.G. Agadianyan, K. Dang, Y. Refaeli, A.I. Sato, J. Boyer, W.V. Williams and D.B. Weiner, Gene inoculation generates immune responses against human immunodeficiency virus type 1, Proc. Natl. Acad. Sci. USA 90 (1993) 4156-4160.
107. J.R. Haynes, M.D. Eisenbraun, D.H. Fuller, E.F. Fynan and H.L. Robinson, In: R.A. Lerner, H. Ginsberg, R.M. Chanock and F. Brown (Eds.), Vaccines 94, Cold Spring Harbor Laboratory Press, 1994, pp. 65-70.
108. H.L. Robinson, L.A. Hunt and R.G. Webster, Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA, Vaccine 11 (1993) 957-960.
109. H.S. Mason, D.M.-K. Lam and C.J. Arntzen, Expression of hepatitis B surface antigen in transgenic plants, Proc. Natl. Acad. Sci. USA 89 (1992) 11745-11749.
110. T.A. Haq, H.S. Mason, J.D. Clements and C.J. Arntzen, Oral immunization with recombinant bacterial antigen produced in transgenic plants, Science 268 (1995) 714-716.